Erhaltungstherapie durch Tucatinib-Zugabe besser wirksam

Im Focus Onkologie 2026

View at publisher

Authors: Katharina Arnheim

DOI: 10.1007/s15015-026-4513-1

Cited by: 0

Fields of Study & Subjects

HER2/EGFR in Cancer Research Gastric Cancer Management and Outcomes Advanced Breast Cancer Therapies